Core Laboratories/$CLB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Core Laboratories
Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
Ticker
$CLB
Sector
Primary listing
NYSE
Employees
3,300
Headquarters
Website
CLB Metrics
BasicAdvanced
$752M
25.92
$0.63
1.15
$0.04
0.24%
Price and volume
Market cap
$752M
Beta
1.15
52-week high
$20.36
52-week low
$9.72
Average daily volume
379K
Dividend rate
$0.04
Financial strength
Current ratio
2.025
Quick ratio
1.354
Long term debt to equity
54.534
Total debt to equity
58.629
Dividend payout ratio (TTM)
5.88%
Interest coverage (TTM)
4.89%
Profitability
EBITDA (TTM)
66.37
Gross margin (TTM)
20.69%
Net profit margin (TTM)
5.63%
Operating margin (TTM)
9.82%
Effective tax rate (TTM)
29.13%
Revenue per employee (TTM)
$160,000
Management effectiveness
Return on assets (TTM)
5.94%
Return on equity (TTM)
12.10%
Valuation
Price to earnings (TTM)
25.921
Price to revenue (TTM)
1.44
Price to book
2.83
Price to tangible book (TTM)
12.93
Price to free cash flow (TTM)
34.01
Free cash flow yield (TTM)
2.94%
Free cash flow per share (TTM)
0.48
Dividend yield (TTM)
0.24%
Forward dividend yield
0.24%
Growth
Revenue change (TTM)
0.51%
Earnings per share change (TTM)
-4.55%
3-year revenue growth (CAGR)
2.44%
10-year revenue growth (CAGR)
-4.07%
3-year earnings per share growth (CAGR)
14.49%
10-year earnings per share growth (CAGR)
-13.48%
10-year dividend per share growth (CAGR)
-33.02%
What the Analysts think about CLB
Analyst ratings (Buy, Hold, Sell) for Core Laboratories stock.
CLB Financial Performance
Revenues and expenses
CLB Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Core Laboratories stock?
Core Laboratories (CLB) has a market cap of $752M as of April 21, 2026.
What is the P/E ratio for Core Laboratories stock?
The price to earnings (P/E) ratio for Core Laboratories (CLB) stock is 25.92 as of April 21, 2026.
Does Core Laboratories stock pay dividends?
Yes, the Core Laboratories (CLB) stock pays dividends to shareholders. As of April 21, 2026, the dividend rate is $0.04 and the yield is 0.24%. Core Laboratories has a payout ratio of 5.88% on a trailing twelve-month basis.
When is the next Core Laboratories dividend payment date?
The next Core Laboratories (CLB) dividend payment date is unconfirmed.
What is the beta indicator for Core Laboratories?
Core Laboratories (CLB) has a beta rating of 1.15. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.